About Genepharm India Private Limited
Data last updated:
Genepharm India Private Limited was a private limited company based in Kolkata, West Bengal, India, operated as a subsidiary of Genepharm S.A. Pharmaceutical Co.. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the speciality chemicals segment of the chemicals sector. It was incorporated on 29 June 2006.
The company was registered with the Registrar of Companies (ROC), Kolkata, under CIN U24239WB2006PTC110197.
The company had an authorised share capital of ₹45 Lakh and a paid-up capital of ₹21.28 Lakh. It was led by directors Neena Sanjay Katrekar and Venkat Kamalakar Bundla.
Its last annual general meeting (AGM) was held on 26 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at 1B Old Post Officie Street Kolkata – 700001, West Bengal, India – 700001.
The company was associated with 1 brand: Genepharm.
The last known website on record is genepharm.com.
Company details
Contact details
Genepharm India Private Limited's registered office is in Kolkata, West Bengal.
- Social Media
- Registered Address1B Old Post Officie Street Kolkata – 700001, West Bengal, India – 700001
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Genepharm India operates one associated brand: Genepharm. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Generic drugs are manufactured in Pallini, Greece. | genepharm.com |
Financials of Genepharm India Private Limited
FY 2016 filings availableFinancial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Genepharm India Private Limited, buy the company report.
Board of directors of Genepharm India Private Limited
Genepharm India has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neena Sanjay Katrekar | Director | 30 Mar 2009 | 17 Years 6 Months | As last reported |
| Venkat Kamalakar Bundla Also directs: Biodoz Therapeutics Private Limited, Eventooz Private Limited, Garphi Biosciences Private Limited and 1 more | Additional Director | 07 Jun 2012 | 14 Years 4 Months | As last reported |
Legal cases
No court or tribunal cases involving Genepharm India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Genepharm India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Genepharm India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Genepharm India Private Limited has 4 board changes on record since 2009: 2 appointments and 2 cessations. The latest: Aakash Choubey ceased to be Director on 21 Aug 2012.
Frequently asked questions
Genepharm India has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Genepharm India was a private limited company based in Kolkata, West Bengal, India. The company worked in other chemical product, within the chemicals industry. It was incorporated on 29 June 2006 and is registered under CIN U24239WB2006PTC110197. The company has been struck off by the Registrar of Companies and is no longer operational.
Genepharm India had 2 directors:
- Neena Sanjay Katrekar - Director
- Venkat Kamalakar Bundla - Additional Director
The CIN (Corporate Identification Number) of Genepharm India is U24239WB2006PTC110197. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Genepharm India is at 1B Old Post Officie Street Kolkata – 700001, West Bengal, India – 700001.
Genepharm India was incorporated on 29 June 2006. It is registered with the Registrar of Companies, Kolkata.
Genepharm India can be reached through the website genepharm.com. Its registered office is in Kolkata, West Bengal, India.
The latest financial statements of Genepharm India on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 26 September 2016. Year-wise statements from 2015 are in the company report.
Genepharm India operated in the chemicals industry, in the other chemical product segment. It worked in this industry before it was struck off.
Aakash Choubey ceased to be Director on 21 Aug 2012. Venkat Kamalakar Bundla was appointed as Additional Director on 07 Jun 2012. Trivikram Khaitan ceased to be Director on 15 Sep 2010. Genepharm India has 4 board changes on record in total.